Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

Sugen reports antihyperproliferative agents

Dec. 10, 1996

British Biotech discontinues development of MMP inhibitor

Dec. 9, 1996

Access in-licenses polymer platinum compounds

Dec. 9, 1996

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

Varian, University of Arizona collaborate on methods of enhancing gene therapy efficacy

Dec. 6, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

RPR continues research into taxanes

Dec. 5, 1996

Calydon's lead cancer therapeutic progresses toward clinical trials

Dec. 4, 1996

Schering-Plough continues research into FPTase inhibitors

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...